Efficacy and Safety of Pitavastatin/Ezetimibe Fixed-Dose Combination vs. Pitavastatin: Phase III, Double-Blind, Randomized Controlled Trial.

Kenichi Tsujita,Koutaro Yokote,Junya Ako,Ryohei Tanigawa,Sachiko Tajima,Hideki Suganami

Journal of atherosclerosis and thrombosis（2023）

引用 0|浏览7

暂无评分

摘要

The pitavastatin/ezetimibe fixed-dose combination showed an excellent LDL-C-reducing effect by the complementary pharmacological action of each component, and its safety profile was similar to that of pitavastatin monotherapy (ClinicalTrials.gov Identifier: NCT04289649).

查看译文

关键词

Ezetimibe,Fixed-dose combination,Hypercholesterolemia,Pitavastatin

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要